178 related articles for article (PubMed ID: 24997889)
1. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
[TBL] [Abstract][Full Text] [Related]
2. [Follow-up of patients treated by VKA: Interest of a pharmaceutical link between the hospital and the retail pharmacies].
Bidon D; Lecoeur A; Segui E; Seguette N; Le Mercier F; Bauler S
Ann Pharm Fr; 2017 Jan; 75(1):45-53. PubMed ID: 27234455
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of the knowledge of patients about the management of treatment with anti-vitamin K drugs in the Service of Cardiology of Ouagadougou].
Samadoulougou AK; Naibe DT; Mandi DG; Kabore E; Millogo GR; Yameogo NV; Kologo JK; Tall AT; Toguyeni BJ; Zabsonre P
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):263-7. PubMed ID: 26275496
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic education of elderly patients under antivitamin - K treatment: evaluation of the program after 5 years].
Thiriat N; Peyron I; Bernard-Charrière S; Monti A; Pariel S; Pautas E
J Pharm Belg; 2014 Sep; (3):30-7. PubMed ID: 25226761
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
6. Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients.
Kooistra HA; Piersma-Wichers M; Kluin-Nelemans HC; Veeger NJ; Meijer K
Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):388-94. PubMed ID: 27329860
[TBL] [Abstract][Full Text] [Related]
7. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in children participating in a non-selective INR self-monitoring VKA-education programme.
Amedro P; Bajolle F; Bertet H; Cheurfi R; Lasne D; Nogue E; Auquier P; Picot MC; Bonnet D
Arch Cardiovasc Dis; 2018 Mar; 111(3):180-188. PubMed ID: 29100908
[TBL] [Abstract][Full Text] [Related]
9. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
10. Development of a tool to identify patients' preference for vitamin K antagonist or direct oral anticoagulant therapy.
Zolfaghari S; Harenberg J; Froelich L; Wehling M; Weiss C
Semin Thromb Hemost; 2014 Feb; 40(1):121-8. PubMed ID: 24381153
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of vitamin K antagonist overcoagulation.
Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
[TBL] [Abstract][Full Text] [Related]
13. Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.
Suárez-Pinilla M; Fernández-Rodríguez Á; Benavente-Fernández L; Calleja-Puerta S
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):732-42. PubMed ID: 23954605
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
Mahaffey KW; Wojdyla D; Hankey GJ; White HD; Nessel CC; Piccini JP; Patel MR; Berkowitz SD; Becker RC; Halperin JL; Singer DE; Califf RM; Fox KA; Breithardt G; Hacke W
Ann Intern Med; 2013 Jun; 158(12):861-8. PubMed ID: 23778903
[TBL] [Abstract][Full Text] [Related]
15. [Therapy education for patients receiving oral anti-coagulants vitamin K antagonists].
Satger B; Blaise S; Fontaine M; Yver J; Allenet B; Baudrant M; Pernod G; Bosson JL
Presse Med; 2009 Dec; 38(12):1780-7. PubMed ID: 19815369
[TBL] [Abstract][Full Text] [Related]
16. [Decisional algorithm to prescribe vitamin K antagonist in geriatric patients with atrial fibrillation].
Sibai MS; Bellarbre F; Ghazali N; Bureau ML; Priner M; Ingrand P; Paccalin M
Geriatr Psychol Neuropsychiatr Vieil; 2014 Mar; 12(1):20-4. PubMed ID: 24647235
[TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
[TBL] [Abstract][Full Text] [Related]
18. [Does acetylsalicylic acid and vitamin K antagonists are risk factors of macular degeneration related with age?].
Jończyk-Skórka K; Śliwczyńska-Rodziewicz D; Jarmak A; Kowalski J
Pol Merkur Lekarski; 2015 Mar; 38(225):144-9. PubMed ID: 25815614
[TBL] [Abstract][Full Text] [Related]
19. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].
Soave C; Chidlovskii E; Lebelhomme A; Gaboreau Y; Pernod G; Bosson JL; Couturier P
Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13(3):279-88. PubMed ID: 26395301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
